Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy

Por Skrombolas, Denise, Frelinger, John G.
Publicado em 2014

Characterization of an IL-12 p40/p35 Truncated Fusion Protein That Can Inhibit the Action of IL-12

Por Skrombolas, Denise, Wylie, Isabel, Maharaj, Shivana, Frelinger, John G.
Publicado no J Interferon Cytokine Res (2015)

Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases

Por Puskas, John, Skrombolas, Denise, Sedlacek, Abigail, Lord, Edith, Sullivan, Mark, Frelinger, John
Publicado em 2011

Expanded CD23+/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy

Por Li, Jie, Kuzin, Igor, Moshkani, Safiehkhatoon, Proulx, Steven T., Xing, Lianping, Skrombolas, Denise, Dunn, Robert, Sanz, Iñaki, Schwarz, Edward M., Bottaro, Andrea
Publicado em 2010

Local expression of interleukin‐2 by B16 melanoma cells results in decreased tumour growth and long‐term tumour dormancy

Por Gerber, Scott A., Sorensen, Elizabeth W., Sedlacek, Abigail L., Lim, Joanne Y. H., Skrombolas, Denise, Frelinger, John G., Lord, Edith M.
Publicado em 2013

Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS

Por Valentino, Michael D., Hensley, Lucinda L., Skrombolas, Denise, McPherson, Pamela L., Woolard, Matthew D., Kawula, Thomas H., Frelinger, Jeffrey A., Frelinger, John G.
Publicado em 2009

A broadly applicable approach to T cell epitope identification: Application to improving tumor associated epitopes and identifying epitopes in complex pathogens

Por Valentino, Michael D., Abdul-Alim, C. Siddiq, Maben, Zachary J., Skrombolas, Denise, Hensley, Lucinda L., Kawula, Thomas H., Dziejman, Michelle, Lord, Edith M., Frelinger, Jeffrey A., Frelinger, John G.
Publicado em 2011